Immediate Impact
16 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Works of Satoshi Yanagida being referenced
Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma
2021
ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Satoshi Yanagida | 124 | 101 | 61 | 15 | 204 | |
| Emily Berry | 106 | 104 | 71 | 16 | 247 | |
| Mae Zakhour | 114 | 76 | 45 | 15 | 230 | |
| E.A. Dubil | 52 | 120 | 71 | 12 | 235 | |
| Barnaby Rufford | 165 | 99 | 36 | 12 | 236 | |
| Hisham Abou-Taleb | 159 | 90 | 81 | 20 | 294 | |
| Angela Gambino | 73 | 79 | 63 | 14 | 230 | |
| Peng-Hui Wang | 132 | 77 | 79 | 16 | 247 | |
| Brenda Hermsen | 151 | 55 | 40 | 14 | 273 | |
| Qitao Zhan | 63 | 69 | 72 | 15 | 253 | |
| Jack Basil | 95 | 75 | 46 | 17 | 252 |
All Works
Login with ORCID to disown or claim papers
Loading papers...